BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

196 related articles for article (PubMed ID: 25607725)

  • 1. Yes-associated protein regulates the growth of human non-small cell lung cancer in response to matrix stiffness.
    Yuan Y; Zhong W; Ma G; Zhang B; Tian H
    Mol Med Rep; 2015 Jun; 11(6):4267-72. PubMed ID: 25607725
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mst1 overexpression inhibited the growth of human non-small cell lung cancer in vitro and in vivo.
    Xu CM; Liu WW; Liu CJ; Wen C; Lu HF; Wan FS
    Cancer Gene Ther; 2013 Aug; 20(8):453-60. PubMed ID: 23928732
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Inhibition of CXCR4 regulates epithelial mesenchymal transition of NSCLC via the Hippo-YAP signaling pathway.
    Zheng CH; Chen XM; Zhang FB; Zhao C; Tu SS
    Cell Biol Int; 2018 Sep; 42(10):1386-1394. PubMed ID: 29972256
    [TBL] [Abstract][Full Text] [Related]  

  • 4. ANKHD1 promotes proliferation and invasion of non‑small‑cell lung cancer cells via regulating YAP oncoprotein expression and inactivating the Hippo pathway.
    Liu XF; Han Q; Rong XZ; Yang M; Han YC; Yu JH; Lin XY
    Int J Oncol; 2020 May; 56(5):1175-1185. PubMed ID: 32319569
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Inhibin βA is an independent prognostic factor that promotes invasion via Hippo signaling in non‑small cell lung cancer.
    Zhang Y; Yan S; Li Y; Zhang J; Luo Y; Li P; Yang Y; Li Y; Huang Y; Wang E
    Mol Med Rep; 2021 Nov; 24(5):. PubMed ID: 34505633
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Knockdown of lncRNA GHET1 suppresses cell proliferation, invasion and LATS1/YAP pathway in non small cell lung cancer.
    Guan ZB; Cao YS; Li Y; Tong WN; Zhuo AS
    Cancer Biomark; 2018 Feb; 21(3):557-563. PubMed ID: 29286919
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of Mst1 overexpression on the growth of human hepatocellular carcinoma HepG2 cells and the sensitivity to cisplatin in vitro.
    Xu C; Liu C; Huang W; Tu S; Wan F
    Acta Biochim Biophys Sin (Shanghai); 2013 Apr; 45(4):268-79. PubMed ID: 23419720
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Inhibition of ERK1/2 down-regulates the Hippo/YAP signaling pathway in human NSCLC cells.
    You B; Yang YL; Xu Z; Dai Y; Liu S; Mao JH; Tetsu O; Li H; Jablons DM; You L
    Oncotarget; 2015 Feb; 6(6):4357-68. PubMed ID: 25738359
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Expression of LATS1 contributes to good prognosis and can negatively regulate YAP oncoprotein in non-small-cell lung cancer.
    Lin XY; Zhang XP; Wu JH; Qiu XS; Wang EH
    Tumour Biol; 2014 Jul; 35(7):6435-43. PubMed ID: 24682895
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Lentiviral vector-mediated siRNA knockdown of the YAP gene inhibits growth and induces apoptosis in the SGC7901 gastric cancer cell line.
    Zhou Z; Zhu JS; Xu ZP; Zhang Q
    Mol Med Rep; 2011; 4(6):1075-82. PubMed ID: 21805037
    [TBL] [Abstract][Full Text] [Related]  

  • 11. PDK-1 mediated Hippo-YAP-IRS2 signaling pathway and involved in the apoptosis of non-small cell lung cancer cells.
    Wang G; Liu X; Xie J; Meng J; Ni X
    Biosci Rep; 2019 May; 39(5):. PubMed ID: 30988063
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Neuregulin 1-activated ERBB4 interacts with YAP to induce Hippo pathway target genes and promote cell migration.
    Haskins JW; Nguyen DX; Stern DF
    Sci Signal; 2014 Dec; 7(355):ra116. PubMed ID: 25492965
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Fascin 1 promoted the growth and migration of non-small cell lung cancer cells by activating YAP/TEAD signaling.
    Liang Z; Wang Y; Shen Z; Teng X; Li X; Li C; Wu W; Zhou Z; Wang Z
    Tumour Biol; 2016 Aug; 37(8):10909-15. PubMed ID: 26886283
    [TBL] [Abstract][Full Text] [Related]  

  • 14. TNFAIP8 regulates Hippo pathway through interacting with LATS1 to promote cell proliferation and invasion in lung cancer.
    Han Y; Tang Z; Zhao Y; Li Q; Wang E
    Mol Carcinog; 2018 Feb; 57(2):159-166. PubMed ID: 28926138
    [TBL] [Abstract][Full Text] [Related]  

  • 15. YAP promotes malignant progression of Lkb1-deficient lung adenocarcinoma through downstream regulation of survivin.
    Zhang W; Gao Y; Li F; Tong X; Ren Y; Han X; Yao S; Long F; Yang Z; Fan H; Zhang L; Ji H
    Cancer Res; 2015 Nov; 75(21):4450-7. PubMed ID: 26363011
    [TBL] [Abstract][Full Text] [Related]  

  • 16. YAP mediates the positive regulation of hnRNPK on the lung adenocarcinoma H1299 cell growth.
    Xu L; Zhang T; Huang W; Liu X; Lu J; Gao X; Zhang YF; Liu L
    Acta Biochim Biophys Sin (Shanghai); 2019 Jul; 51(7):677-687. PubMed ID: 31187136
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Activation of Aurora A kinase increases YAP stability via blockage of autophagy.
    Wang P; Gong Y; Guo T; Li M; Fang L; Yin S; Kamran M; Liu Y; Xu J; Xu L; Peng F; Xue X; Yang M; Hung MC; Lam EW; Gu C; Wang C; Zhan Q; Liu Q
    Cell Death Dis; 2019 Jun; 10(6):432. PubMed ID: 31160567
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cucurbitacin E inhibits the Yes‑associated protein signaling pathway and suppresses brain metastasis of human non‑small cell lung cancer in a murine model.
    Hsu PC; Tian B; Yang YL; Wang YC; Liu S; Urisman A; Yang CT; Xu Z; Jablons DM; You L
    Oncol Rep; 2019 Aug; 42(2):697-707. PubMed ID: 31233205
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Insulin-like growth factor binding protein-3 inhibits the growth of non-small cell lung cancer.
    Lee HY; Chun KH; Liu B; Wiehle SA; Cristiano RJ; Hong WK; Cohen P; Kurie JM
    Cancer Res; 2002 Jun; 62(12):3530-7. PubMed ID: 12068000
    [TBL] [Abstract][Full Text] [Related]  

  • 20. CD44 acts through RhoA to regulate YAP signaling.
    Zhang Y; Xia H; Ge X; Chen Q; Yuan D; Chen Q; Leng W; Chen L; Tang Q; Bi F
    Cell Signal; 2014 Nov; 26(11):2504-13. PubMed ID: 25101858
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.